Verma J, Anwar M, Linz B, Backert S, Pachathundikandi S
Biomedicines. 2025; 13(1).
PMID: 39857645
PMC: 11761556.
DOI: 10.3390/biomedicines13010061.
Kuang W, Xu J, Xu F, Huang W, Majid M, Shi H
Front Cell Dev Biol. 2024; 12:1513426.
PMID: 39720008
PMC: 11666564.
DOI: 10.3389/fcell.2024.1513426.
Zhang M, Liu T, Luo L, Zhang Y, Chen Q, Wang F
Front Immunol. 2024; 15:1492810.
PMID: 39712025
PMC: 11659760.
DOI: 10.3389/fimmu.2024.1492810.
Elger W, Tegtmeyer N, Rohde M, Linz B, Hirsch C, Backert S
Cell Commun Signal. 2024; 22(1):578.
PMID: 39627817
PMC: 11613870.
DOI: 10.1186/s12964-024-01948-5.
Santacroce L, Topi S, Bottalico L, Charitos I, Jirillo E
Curr Issues Mol Biol. 2024; 46(5):4991-5009.
PMID: 38785567
PMC: 11119845.
DOI: 10.3390/cimb46050299.
The pathogenicity island as a determinant of gastric cancer risk.
Tran S, Bryant K, Cover T
Gut Microbes. 2024; 16(1):2314201.
PMID: 38391242
PMC: 10896142.
DOI: 10.1080/19490976.2024.2314201.
Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6.
Zhang X, He Y, Zhang X, Fu B, Song Z, Wang L
Gastric Cancer. 2024; 27(2):324-342.
PMID: 38310631
PMC: 10896808.
DOI: 10.1007/s10120-023-01461-7.
Pathogenomics of Helicobacter pylori.
Yamaoka Y, Saruuljavkhlan B, Alfaray R, Linz B
Curr Top Microbiol Immunol. 2024; 444:117-155.
PMID: 38231217
DOI: 10.1007/978-3-031-47331-9_5.
Immune Biology and Persistence of Helicobacter pylori in Gastric Diseases.
Fuchs S, Gong R, Gerhard M, Mejias-Luque R
Curr Top Microbiol Immunol. 2024; 444:83-115.
PMID: 38231216
DOI: 10.1007/978-3-031-47331-9_4.
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M
Front Immunol. 2023; 14:1244345.
PMID: 37822929
PMC: 10562563.
DOI: 10.3389/fimmu.2023.1244345.
Designing and development of multi-epitope chimeric vaccine against Helicobacter pylori by exploring its entire immunogenic epitopes: an immunoinformatic approach.
Keshri A, Kaur R, Rawat S, Arora N, Pandey R, Kumbhar B
BMC Bioinformatics. 2023; 24(1):358.
PMID: 37740175
PMC: 10517479.
DOI: 10.1186/s12859-023-05454-2.
New Promising Routes in Peptic Ulcers: Toll-like Receptors and Semaphorins.
Jacob T, Doshi G
Endocr Metab Immune Disord Drug Targets. 2023; 24(8):865-878.
PMID: 37605412
DOI: 10.2174/1871530323666230821102718.
The TLR/MyD88 signalling cascade in inflammation and gastric cancer: the immune regulatory network of Helicobacter pylori.
Liu M, Hu Z, Wang C, Zhang Y
J Mol Med (Berl). 2023; 101(7):767-781.
PMID: 37195446
DOI: 10.1007/s00109-023-02332-5.
Designed Ankyrin Repeat Proteins provide insights into the structure and function of CagI and are potent inhibitors of CagA translocation by the Helicobacter pylori type IV secretion system.
Blanc M, Lettl C, Guerin J, Vieille A, Furler S, Briand-Schumacher S
PLoS Pathog. 2023; 19(5):e1011368.
PMID: 37155700
PMC: 10194873.
DOI: 10.1371/journal.ppat.1011368.
Intersections between innate immune response and gastric cancer development.
Villarroel-Espindola F, Ejsmentewicz T, Gonzalez-Stegmaier R, Jorquera R, Salinas E
World J Gastroenterol. 2023; 29(15):2222-2240.
PMID: 37124883
PMC: 10134417.
DOI: 10.3748/wjg.v29.i15.2222.
Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging.
Lopes C, Almeida T, Pimentel-Nunes P, Dinis-Ribeiro M, Pereira C
Front Immunol. 2023; 14:1134785.
PMID: 37063848
PMC: 10102473.
DOI: 10.3389/fimmu.2023.1134785.
Molecular architecture of bacterial type IV secretion systems.
Sheedlo M, Ohi M, Lacy D, Cover T
PLoS Pathog. 2022; 18(8):e1010720.
PMID: 35951533
PMC: 9371333.
DOI: 10.1371/journal.ppat.1010720.
Innate Immunity Crosstalk with : Pattern Recognition Receptors and Cellular Responses.
Cheok Y, Tan G, Lee C, Abdullah S, Looi C, Wong W
Int J Mol Sci. 2022; 23(14).
PMID: 35886908
PMC: 9317022.
DOI: 10.3390/ijms23147561.
Animal Models and Infection.
Ansari S, Yamaoka Y
J Clin Med. 2022; 11(11).
PMID: 35683528
PMC: 9181647.
DOI: 10.3390/jcm11113141.
Pathogen-Associated Molecular Patterns: Friends or Foes?.
Eletto D, Mentucci F, Voli A, Petrella A, Porta A, Tosco A
Int J Mol Sci. 2022; 23(7).
PMID: 35408892
PMC: 8998707.
DOI: 10.3390/ijms23073531.